Detalles de la búsqueda
1.
Noninvasive Early Identification of Therapeutic Benefit from Immune Checkpoint Inhibition.
Cell
; 183(2): 363-376.e13, 2020 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33007267
2.
Global analysis of shared T cell specificities in human non-small cell lung cancer enables HLA inference and antigen discovery.
Immunity
; 54(3): 586-602.e8, 2021 03 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33691136
3.
Integrating genomic features for non-invasive early lung cancer detection.
Nature
; 580(7802): 245-251, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32269342
4.
Immune Checkpoint Inhibitor Cardiotoxicity: Understanding Basic Mechanisms and Clinical Characteristics and Finding a Cure.
Annu Rev Pharmacol Toxicol
; 61: 113-134, 2021 01 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32776859
5.
Risk model-based management for second primary lung cancer among lung cancer survivors through a validated risk prediction model.
Cancer
; 130(5): 770-780, 2024 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37877788
6.
The effect of neighborhood socioeconomic disadvantage on smoking status, quit attempts, and receipt of cessation support among adults with cancer: Results from nine ECOG-ACRIN Cancer Research Group trials.
Cancer
; 130(3): 439-452, 2024 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37795845
7.
A process to reanalyze clinical DNA sequencing data for biomarker matching in the Lung-MAP Master Protocol.
Oncologist
; 2024 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38597608
8.
Identification of Pathogenic Immune Cell Subsets Associated With Checkpoint Inhibitor-Induced Myocarditis.
Circulation
; 146(4): 316-335, 2022 07 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-35762356
9.
Giant Magnetoresistive Nanosensor Analysis of Circulating Tumor DNA Epidermal Growth Factor Receptor Mutations for Diagnosis and Therapy Response Monitoring.
Clin Chem
; 67(3): 534-542, 2021 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33393992
10.
Improved survival and disease control following pembrolizumab-induced immune-related adverse events in high PD-L1 expressing non-small cell lung cancer with brain metastases.
J Neurooncol
; 152(1): 125-134, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33415659
11.
Osimertinib for EGFR-Mutant Lung Cancer with Brain Metastases: Results from a Single-Center Retrospective Study.
Oncologist
; 24(6): 836-843, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30126856
12.
Case series of MET exon 14 skipping mutation-positive non-small-cell lung cancers with response to crizotinib and cabozantinib.
Anticancer Drugs
; 30(5): 537-541, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30762593
13.
Molecular profiling of single circulating tumor cells from lung cancer patients.
Proc Natl Acad Sci U S A
; 113(52): E8379-E8386, 2016 12 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-27956614
14.
Rociletinib in EGFR-mutated non-small-cell lung cancer.
N Engl J Med
; 372(18): 1700-9, 2015 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-25923550
15.
Improved tumor vascularization after anti-VEGF therapy with carboplatin and nab-paclitaxel associates with survival in lung cancer.
Proc Natl Acad Sci U S A
; 112(5): 1547-52, 2015 Feb 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-25605928
16.
Erlotinib, cabozantinib, or erlotinib plus cabozantinib as second-line or third-line treatment of patients with EGFR wild-type advanced non-small-cell lung cancer (ECOG-ACRIN 1512): a randomised, controlled, open-label, multicentre, phase 2 trial.
Lancet Oncol
; 17(12): 1661-1671, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27825638
17.
Management of Dermatologic Complications of Lung Cancer Therapies.
Curr Treat Options Oncol
; 16(10): 50, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26338208
18.
Immune correlates of talactoferrin alfa in biopsied tumor of relapsed/refractory metastatic non-small cell lung cancer patients.
Immunopharmacol Immunotoxicol
; 36(2): 182-6, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24494587
19.
HER2-Mutant Advanced and/or Metastatic Non-Small-Cell Lung Cancer: A US Electronic Health Records Database Analysis of Clinical Characteristics, Treatment Practice Patterns, and Outcomes.
Clin Lung Cancer
; 2024 Jan 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38403548
20.
Patient Selection and Outcomes for Hypofractionated Accelerated Radiation and Concurrent Chemotherapy for Non-Small-Cell Lung Cancer.
Clin Lung Cancer
; 25(2): e92-e100.e4, 2024 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38065707